pLenti_SSF_MOR_2Ala_APEX2
(Plasmid
#250774)
-
PurposeMammalian cell expression of the mu opioid receptor with L387 and L390 mutated to alanines
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 250774 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepLenti
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameMOR(2Ala)
-
SpeciesM. musculus (mouse)
-
MutationL387 and L400 are mutated to alanines
- Promoter UBC
-
Tags
/ Fusion Proteins
- Signal Sequence FLAG (N terminal on insert)
- APEX2 (C terminal on insert)
Cloning Information
- Cloning method Gibson Cloning
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLenti_SSF_MOR_2Ala_APEX2 was a gift from Braden Lobingier (Addgene plasmid # 250774 ; http://n2t.net/addgene:250774 ; RRID:Addgene_250774) -
For your References section:
Lysosomal down-regulation of the mu opioid receptor is opposed by the Retromer complex. Dagunts A, Adoff H, Novy B, Ameur LB, De Maria M, Saunders A, Lobingier BT. Sci Adv. 2026 Mar 20;12(12):eadx8715. doi: 10.1126/sciadv.adx8715. Epub 2026 Mar 20. 10.1126/sciadv.adx8715 PubMed 41861010